When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GNMSF - Novartis to transition availability of Arzerra for CLL to compassionate use ex-U.S. $50M milestone to partner Genmab
Genmab A/S Dkk
Citing low the low number of chronic lymphocytic leukemia (CLL) being treated with Arzerra (ofatumumab) outside of the U.S., Novartis (NYSE:NVS) will transition the product from commercial availability to limited availability via compassionate use programs in all ex-U.S. markets.
More news on: Novartis AG, Genmab A/S, Healthcare stocks news,